Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Gamified Virtual Reality Exercise for Suicidal Ideation in Older Adults (VR-GAME-SI)

10 de novembro de 2026 atualizado por: Zinat Ebrahimi, Islamic Azad University, Sanandaj

The Effectiveness of a Gamified Virtual Reality-Based Exercise Program on Suicidal Ideation in Older Adults: A Two-Arm Randomized Controlled Trial With 30-Day Follow-Up

This is a two-arm, parallel-group randomized controlled trial designed to evaluate the effectiveness of a gamified virtual reality (VR)-based exercise program in reducing suicidal ideation among community-dwelling older adults, compared with a conventional exercise control condition, and to assess the durability of effects over a 30-day follow-up period. A total of 220 eligible older adults (men and women) aged 60 years and above with clinically confirmed suicidal ideation will be randomized (1:1) to either a 5-week gamified VR-based exercise intervention or a conventional exercise control condition. Both interventions are delivered three times per week for five weeks (15 sessions total). The primary outcome is suicidal ideation severity, measured using the Beck Scale for Suicide Ideation (BSSI) at baseline, post-intervention, and 30-day follow-up. Sex differences in intervention response will be examined as a secondary objective. This study has been approved by the Institutional Review Board of the Sports Sciences Research Center (Approval ID: IR.SSRC.REC.1404.029).

Visão geral do estudo

Descrição detalhada

This study is a two-arm, pretest-posttest randomized controlled trial (RCT) with a 30-day follow-up period. The trial is conducted in Tehran, Iran, to examine the effects of a gamified virtual reality (VR)-based exercise intervention on suicidal ideation among community-dwelling older adults. Participants are randomized (1:1) to either the gamified VR-based exercise intervention or a conventional exercise control condition. Outcomes are assessed at three time points: baseline, immediately after the intervention, and 30 days after the intervention.

Randomization and Allocation: Randomization is conducted using a concealed allocation procedure. Group assignments are generated in advance and placed into sequentially numbered, opaque, sealed envelopes. An independent researcher, not involved in participant assessment or intervention delivery, manages the allocation process to ensure allocation concealment and minimize selection bias. Stratified randomization by sex is applied to ensure a balanced sex distribution across groups. Outcome assessment is conducted by an independent clinical psychologist blinded to group allocation. Participants are instructed not to disclose their assigned condition during assessments. The statistician/data analyst is also blinded to group identity; groups are coded prior to analysis and unblinded only after the primary analyses are completed.

Intervention Details (VR Group): Participants assigned to the experimental group engage in a structured, gamified VR-based exercise program delivered over a 5-week period. The program consists of 15 sessions (three sessions per week), each lasting approximately 30-45 minutes. Sessions are conducted under supervision and incorporate immersive VR environments designed to enhance physical engagement and motivational involvement. Participants use Meta Quest 3 VR headsets (512 GB version) to complete immersive, game-based exercise modules. Three distinct VR training modules are implemented to reduce monotony and sustain engagement. Gamification elements include performance-based feedback, progressive challenges, structured task goals, and individualized non-monetary incentives. Participants' performance scores are recorded across sessions to promote mastery experiences and gradual self-improvement. Friendly competitive elements are incorporated cautiously to enhance engagement while prioritizing psychological safety. Exercise intensity and task progression are carefully supervised to match participants' physical capacity and tolerance. All sessions are supervised by trained personnel, including a sport science specialist and a gamification expert.

Control Group: The control group participates in conventional physical exercise sessions of comparable duration and frequency (5 weeks; 3 sessions/week; 15 sessions) but without VR exposure. Sessions are conducted under supervision and are designed to be comparable in structure and social contact to the VR condition.

Safety Monitoring: Participant safety is monitored throughout all intervention sessions by trained research staff. Prior to each session, participants are asked about any new health concerns, discomfort, or symptoms that might affect their ability to participate safely. During the intervention, participants are continuously observed for signs of fatigue, balance difficulties, dizziness, nausea, headache, visual discomfort, or other symptoms commonly associated with immersive VR exposure. Participants are instructed to immediately report any discomfort. If symptoms occur, the activity is paused and appropriate support is provided. Short rest periods, hydration, and seated recovery are available whenever needed. All VR sessions are conducted in a supervised exercise area cleared of obstacles, and each participant is assigned an individual movement space to minimize collision, loss of balance, or fall risk. Any adverse events or participant-reported symptoms are documented by research staff immediately following the session.

Statistical Analysis Plan: Analyses are performed using SPSS version 27, with statistical significance set at p < .05. Prior to conducting the primary analyses, normality of suicidal ideation scores is examined using the Kolmogorov-Smirnov test. Homogeneity of variances between the experimental and control groups is evaluated using Levene's test. The assumption of homogeneity of regression slopes is examined by testing the interaction between group membership and baseline scores. Analysis of Covariance (ANCOVA) is performed to compare post-intervention and follow-up scores between groups while statistically controlling for baseline scores. Baseline scores are entered as a covariate to adjust for initial differences and to provide a more precise estimation of the intervention effect. Effect sizes are reported using partial eta squared (η²p) to quantify the magnitude of group differences. Sex differences are examined by including Sex as a between-subject factor in exploratory analyses (Group × Time × Sex interaction).

Tipo de estudo

Intervencional

Inscrição (Real)

200

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Tehran Province
      • Tehran, Tehran Province, Irã
        • Elderly care centers

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

60 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  1. Male or female, aged 60 years or older.
  2. Presence of suicidal ideation as indicated by elevated scores on the Beck Scale for Suicide Ideation (BSSI) and clinical confirmation by a licensed psychologist.
  3. Medical clearance from a physician confirming the ability to safely participate in low-to-moderate intensity physical activity.
  4. Ability to understand study procedures and provide informed consent.
  5. Willingness to participate in a 5-week exercise program and attend follow-up assessments.

Exclusion Criteria:

  1. Severe cognitive impairment or neurological disorders that could interfere with questionnaire completion or VR participation.
  2. Diagnosed with acute psychiatric conditions requiring immediate intensive treatment (e.g., active psychosis or high suicide risk requiring hospitalization).
  3. Uncontrolled cardiovascular, musculoskeletal, or other medical conditions contraindicating physical exercise.
  4. Concurrently enrolled in structured psychological or exercise intervention programs that could confound study outcomes.
  5. Withdrawal of consent at any stage of the study.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Gamified VR-Based Exercise Intervention

Participants engage in a structured, gamified virtual reality (VR)-based exercise program delivered over a 5-week period (3 sessions/week; 15 sessions total). Each session lasts approximately 30-45 minutes. Participants use Meta Quest 3 VR headsets (512 GB version) to complete immersive, game-based exercise modules. Three distinct VR training modules are implemented to reduce monotony and sustain engagement. Gamification elements include performance-based feedback, progressive challenges, structured task goals, and individualized non-monetary incentives. Participants' performance scores are recorded across sessions to promote mastery experiences. Sessions are supervised by trained personnel, including a sport science specialist and a gamification expert. Exercise intensity and task progression are carefully supervised to match participants' physical capacity and tolerance.

A 5-week gamified VR-based exercise program delivered three times per week (15 sessions total). Each session lasts approximately 30-45 minutes and is conducted at a low-to-moderate intensity level appropriate for older adults. Participants use Meta Quest 3 VR headsets (512 GB version) to complete immersive, game-based exercise modules. Three distinct VR training modules are implemented to reduce monotony and sustain engagement. Gamification elements include performance-based feedback, progressive challenges, structured task goals, and individualized non-monetary incentives. Sessions are supervised by trained personnel, including a sport science specialist and a gamification expert.

Comparador Ativo: Conventional Exercise Control

Participants engage in conventional physical exercise sessions of comparable duration and frequency (5 weeks; 3 sessions/week; 15 sessions total) but without VR exposure. Sessions are conducted under supervision and are designed to be comparable in structure and social contact to the VR condition. Each session lasts approximately 30-45 minutes and is conducted at a low-to-moderate intensity level appropriate for older adults.

A 5-week conventional physical exercise program delivered three times per week (15 sessions total), matched to the VR condition for frequency and duration. Each session lasts approximately 30-45 minutes and is conducted at a low-to-moderate intensity level appropriate for older adults. Sessions are conducted under supervision and are designed to be comparable in structure and social contact to the VR condition, but without VR exposure.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Suicidal Ideation Severity Score
Prazo: Baseline (pre-intervention), Post-Intervention (Week 5), and 30-Day Follow-Up

Suicidal ideation is measured using the Beck Scale for Suicide Ideation (BSSI), a widely validated instrument designed to measure the severity of suicidal thoughts, plans, and intent. The BSSI consists of 19 items, each rated on a 4-point scale ranging from 0 to 3. Total scores are calculated by summing item responses, yielding a possible score range from 0 to 57, with higher scores indicating greater severity of suicidal ideation. In addition to the self-report assessment, all participants are evaluated by a licensed clinical psychologist to confirm the presence of suicidal ideation prior to enrollment.

Baseline (pre-intervention), Post-Intervention (Week 5), and 30-Day Follow-Up

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Sex Differences in Suicidal Ideation Change
Prazo: Baseline (pre-intervention), Post-Intervention (Week 5), and 30-Day Follow-Up

Between-sex differences in Beck Scale for Suicide Ideation (BSSI) change scores from baseline to post-intervention and from baseline to 30-day follow-up. Sex is included as a between-subject factor in exploratory analyses to assess whether the intervention effect differs between men and women. Scores range from 0 to 57, with higher scores indicating greater severity of suicidal ideation.

Baseline (pre-intervention), Post-Intervention (Week 5), and 30-Day Follow-Up

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

  • Beck, A. T., Kovacs, M., & Weissman, A. (1979). Assessment of suicidal intention: The Scale for Suicide Ideation. Journal of Consulting and Clinical Psychology, 47(2), 343-352. Beck, A. T., Steer, R. A., & Ranieri, W. F. (1988). Scale for Suicide Ideation: Psychometric properties of a self-report version. Journal of Clinical Psychology, 44(4), 499-505.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

10 de maio de 2025

Conclusão Primária (Real)

20 de junho de 2025

Conclusão do estudo (Real)

20 de julho de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

1 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

2 de outubro de 2026

Primeira postagem (Real)

7 de outubro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

13 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de novembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

The datasets generated and analyzed during this study are not publicly available due to institutional data governance policies of the Sports Sciences Research Center, but are available from the corresponding author upon reasonable request.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever